CAS 551942-41-7

Formule : C12H22N4O8

InChI : InChI=1S/C12H20N4O7.H2O/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17;/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16);1H2/t5-,6+,8+,9+,10+;/m0./s1

Code InChI : OELRRAURPSTFEX-VCFRRRQNSA-N

SMILES : CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N.O

Zanamivir Hydrate

CAS : 551942-41-7

Formule : C₁₂H₂₀N₄O₇·xH₂O

Degré de pureté : >98.0%(HPLC)(T)

Couleur et forme : White to Almost white powder to crystal

Masse moléculaire : 332.31

Ref: 3B-Z0023

Zanamivir Hydrate

CAS : 551942-41-7

Zanamivir Hydrate

Formule : C₁₂H₂₀N₄O₇·xH₂O

Degré de pureté : >98%

Masse moléculaire : 332.31

Ref: 54-OR1077427

Zanamivir Hydrate

CAS : 551942-41-7

Formule : C₁₂H₂₂N₄O₈

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 350.3251

Ref: IN-DA00DFJ3

Zanamivir hydrate

CAS : 551942-41-7

Zanamivir hydrate is neuraminidase inhibitors. It is used worldwide for the treatment and prophylaxis of influenza caused by influenza A and B viruses.

Formule : C₁₂H₂₂N₄O₈

Couleur et forme : Solid

Masse moléculaire : 350.3251

Ref: TM-T2529L

Zanamivir hydrate

CAS : 551942-41-7

Potent and selective inhibitor of influenza A and B sialidases (neuraminidases). This compound is a sialic acid analogue that occupies viral neuraminidase active site, inhibits enzyme’s hydrolytic activity and cleavage of sialic acid residues from host cell surface glycans. It therefore prevents shedding newly produced virions from infected cell surface and reduces infection of surrounding cells.

Formule : C₁₂H₂₀N₄O₇•(H₂O)x

Degré de pureté : Min. 95%

Couleur et forme : White Powder

Masse moléculaire : 332.31 g/mol

Ref: 3D-MZ04270

Zanamivir hydrate - Bio-X ™

CAS : 551942-41-7

Potent and selective inhibitor of influenza A and B sialidases. Zanamivir belongs to the class of drugs known as neuraminidase inhibitors. This compound is a sialic acid analogue that occupies viral neuraminidase active site, inhibits enzyme’s hydrolytic activity and cleavage of sialic acid residues from host cell surface glycans. It therefore prevents shedding newly produced virions from infected cell surface and reduces infection of surrounding cells. In in vitro studies with influenza A and B virus isolates, zanamivir inhibited the plaque formation by 50% in canine cells (MDCK) with concentrations between 0.004 and 0.014 μM and 0.02 and 16 μM, respectively. Zanamivir hydrate is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Formule : C₁₂H₂₂N₄O₈

Degré de pureté : (%) Min. 98%

Couleur et forme : Powder

Masse moléculaire : 350.33 g/mol

Ref: 3D-BZ164566

Zanamivir Hydrate

CAS : 551942-41-7

Formule : C₁₂H₂₀N₄O₇X(H₂O)

Masse moléculaire : 332.31 : X(18.0)

Ref: ST-EA-CP-Z16001